Acrivon Therapeutics, Inc.

Ownership Transactions Reported by 18 Insiders

Symbol
ACRV on Nasdaq
Industry
Pharmaceutical Preparations
Location
480 Arsenal Way, Suite 100, Watertown, MA

Insiders trading volume in the past year

Acrivon Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Ra Capital Management, L.P. Director, 10%+ Owner $67.3M Jun 20, 2024
Perceptive Advisors Llc 10%+ Owner $45.6M +$20M +78.2% Apr 11, 2024
Kristina Masson EVP - Business Operations, Director $19.8M Aug 14, 2024
Peter Blume-Jensen President and CEO, Director $17.1M Nov 21, 2024
Chione Ltd 10%+ Owner $16.7M Jun 26, 2023
Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10%+ Owner $3.86M Nov 17, 2022
Eric Devroe Chief Operating Officer $538K Nov 14, 2024
Mary Miller Chief Legal Officer $300K Nov 14, 2024
Rasmus Holm-Jorgensen Chief Financial Officer $210K Nov 14, 2024
Erick Gamelin Chief Development Officer $134K Nov 14, 2024
Katharine Peterson Chief Accounting Officer $35.9K Nov 14, 2024
Jean-Marie Cuillerot Chief Medical Officer Jan 11, 2024
Ivana Magovcevic-Liebisch Director Feb 8, 2024
Sharon Shacham Director Jun 20, 2024
Charles M. Baum Director Jun 20, 2024
Derek DiRocco Director Jun 20, 2024
Michael John Tomsicek Director Jun 20, 2024
Santhosh Palani Director Mar 4, 2024

Recent Insider Transactions by Companies or Individuals for Acrivon Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.